Bharat Biotech to supply Covaxin to Brazil
3 years, 11 months ago

Bharat Biotech to supply Covaxin to Brazil

The Hindu  

Covaxin maker Bharat Biotech has signed an agreement with Precisa Medicamentos, a firm in Brazil, to supply the COVID-19 vaccine candidate to the Latin American country. Tuesday’s announcement about the agreement follows a Precisa Medicamentos team visiting Bharat Biotech last week to discuss potential export possibilities. Supplies to the private market would be based upon receipt of market authorization from ANVISA, the Brazilian regulatory authority,” a release from Bharat Biotech said. Our goal for all vaccines developed at Bharat Biotech is to provide global access to populations that need it the most.” According to WHO data, Brazil has had over eight million confirmed COVID-19 cases and the number of deaths, due to the virus, were over 2,03,100.

India Brazil Covid Bharat Vaccine Bharat Biotech Biotech Precisa Medicamentos Supply Covaxin  vaccines  vaccine  bharat  precisa  market  medicamentos  covid19  supply  covaxin  biotech  brazil

History of this topic

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses
2 years ago

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses

News 18  

Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of Covid-19 vaccines ready to dispatch as and when orders are received. According to respective company sources, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

WHO suspends UN supply of Covaxin over manufacturing deficiencies, Bharat Biotech slows down production
2 years, 9 months ago

WHO suspends UN supply of Covaxin over manufacturing deficiencies, Bharat Biotech slows down production

India Today  

In a setback to India’s indigenous vaccine against Covid-19, the World Health Organisation has issued a statement saying that the body is suspending the supply of Bharat Biotech’s Covaxin through UN agencies. A day earlier, Bharat Biotech issued a statement saying the company “announces the temporary slowing down of production of Covaxin across its manufacturing facilities, having completed its supply …

Bharat Biotech says upgrading Covaxin facilities as WHO suspends vaccine supplies
2 years, 9 months ago

Bharat Biotech says upgrading Covaxin facilities as WHO suspends vaccine supplies

India TV News  

Highlights The WHO has suspended the supply of Covaxin vaccine under the United Nations procurement The development comes after an inspection of the COVID-19 vaccine last month Earlier too, Bharat Biotech had said it is working on further improvements and upgrades Bharat Biotech has said it is working on upgrades to ensure that the production of Covaxin continues to meet …

WHO suspends Covaxin supply to UN agencies
2 years, 9 months ago

WHO suspends Covaxin supply to UN agencies

Deccan Chronicle  

Hyderabad: The World Health Organization has confirmed it has suspended the supply of Covaxin, produced by city-based Bharat Biotech, through UN procurement agencies and recommending to countries that received the covid vaccine to take actions as appropriate. A statement issued by WHO on Saturday said the suspension is in response to the outcomes of its post EUL inspection held between …

Panel pitches full market nod for Covaxin, Covishield
2 years, 11 months ago

Panel pitches full market nod for Covaxin, Covishield

Hindustan Times  

The subject expert panel of the national drugs regulator on Wednesday recommended full market authorisation for both Covaxin and Covishield under certain conditions, according to people familiar with the developments. Serum Institute of India and Bharat Biotech International Ltd, manufacturers of Covishield and Covaxin respectively, separately applied to the central drugs standard control organisation to seek full market authorisation stating …

After SII's Covishield, Bharat Biotech Seeks Full Market Approval for Covaxin; SEC to Review Both Today
2 years, 11 months ago

After SII's Covishield, Bharat Biotech Seeks Full Market Approval for Covaxin; SEC to Review Both Today

News 18  

Bharat Biotech has sought full market approval for its Covid vaccine Covaxin from the country’s drug regulator, CNN-News18 has learnt from government sources. For full market authorisation, the regulator would need to evaluate more data about the vaccines collected over a longer period of time. Bharat Biotech’s Covaxin has also been exported to several counties through India’s Vaccine Maitri programme …

Gavi and Bharat Biotech discuss possible COVAX use of Covaxin
3 years ago

Gavi and Bharat Biotech discuss possible COVAX use of Covaxin

Live Mint  

The Gavi vaccine alliance is in talks with India's Bharat Biotech over potential procurement of the company's Covaxin COVID-19 shot for the COVAX global vaccine distribution programme, a Gavi spokesperson told Reuters on Thursday. The World Health Organization in November gave Covaxin, India's first homegrown COVID-19 vaccine, approval for emergency use. Gavi said it was also working with the Serum …

Bharat Biotech to donate 2 lakh doses of covaxin to Vietnam
3 years ago

Bharat Biotech to donate 2 lakh doses of covaxin to Vietnam

Live Mint  

Bharat Biotech will donate 2,00,000 doses of covaxin to The Republic of Vietnam, the Hyderabad based pharmaceutical company said on Thursday. This donation represents a gesture of goodwill to provide access to Bharat Biotech World Health Organization approved, indigenously developed covaxin to fight the covid-19 pandemic across borders, Suchitra Ella, Joint Managing Director of Bharat Biotech said. Bharat Biotech was …

Australia recognises Bharat Biotech’s Covaxin for travellers
3 years, 2 months ago

Australia recognises Bharat Biotech’s Covaxin for travellers

Op India  

On November 1, the Australian Government’s Therapeutic Goods Administration under the Department of Health recognized made-in-India Covid-19 vaccine Covaxin by Bharat Biotech to establish a traveller’s vaccination status. In a statement, Australia’s High Commissioner to India, Barry O’Farrell AO, said, “Australian Government recognises Bharat Biotech’s Covaxin for the purpose of establishing a traveller’s vaccination status.” Australian Government recognises Bharat Biotech’s …

WHO Reviewing Data on Bharat Biotech’s Covaxin, Decision on Approval in '24 Hours or So'
3 years, 2 months ago

WHO Reviewing Data on Bharat Biotech’s Covaxin, Decision on Approval in '24 Hours or So'

News 18  

The World Health Organization was reviewing data on Covaxin, India’s indigenously-made vaccine against Covid-19 and will announce a decision on its Emergency Use Listing in “24 hours or so” a spokesperson said. WHO Chief Scientist Soumya Swaminathan had said in a tweet earlier that the technical advisory group at the organisation will meet on October 26 to consider the much-coveted …

Working with WHO for Covaxin approval, Bharat Biotech says after reports of delay
3 years, 3 months ago

Working with WHO for Covaxin approval, Bharat Biotech says after reports of delay

India Today  

Hyderabad-based Bharat Biotech on Tuesday said it is working with the World Health Organisation for approval of emergency use authorisation for Covaxin, the Covid vaccine developed in India, at the earliest. "We request media organisations to exercise restraint while reporting on public health-related issues and timelines, as it has an impact on millions of lives and livelihoods," Bharat Biotech said …

Why Bharat Biotech’s Covaxin Failed to be the Hero of India’s Fight Against Covid-19
3 years, 3 months ago

Why Bharat Biotech’s Covaxin Failed to be the Hero of India’s Fight Against Covid-19

News 18  

Complex processes, scattered production units, need for more safety zones and shortage of skilled staffers are some of the top reasons that restricted Bharat Biotech’s Covaxin from becoming the poster-boy of India’s vaccination story against Covid-19. On January 4, Bharat Biotech’s managing director Dr Krishna Ella had said in a virtual press briefing that the company is aiming to manufacture …

Bharat Biotech rejects charges that some batches of Covaxin weren't of 'right quality', slowed supply
3 years, 5 months ago

Bharat Biotech rejects charges that some batches of Covaxin weren't of 'right quality', slowed supply

India Today  

Days after some media reports raised concerns over the quality of some batches of Bharat Biotech's Covaxin, the vaccine manufacturer has issued a clarification saying all its vaccine batches are subjected to over 200 quality control checks. Recently, some media reports had claimed that supply of Covaxin were slowed down because the first few batches of the vaccine produced at …

Brazil defers import of Covaxin after Bharat Bioetch terminates pact with local partners
3 years, 5 months ago

Brazil defers import of Covaxin after Bharat Bioetch terminates pact with local partners

Firstpost  

The decision comes in the wake of the MoU between Bharat Biotech and the Brazilian government for the supply of 20 million doses of Covaxin landed in controversy and attracted investigation by authorities Hyderabad: After suspending the proposed clinical trials of Bharat Bioetch’s COVID-19 vaccine Covaxin and a request for Emergency Use Authorisation, Brazil now has suspended its decision to …

The troubles of Bharat Biotech’s US partner is bad news for India’s pharma industry
3 years, 5 months ago

The troubles of Bharat Biotech’s US partner is bad news for India’s pharma industry

Live Mint  

Two months before Ocugen, the US partner of Bharat Biotech International Ltd, announced its partnership with the company for bringing the covid-19 vaccine to the US, it was facing the threat of its shares being delisted from Nasdaq. In a class-action lawsuit filed in the district of Pennsylvania this month, shareholders of Ocugen alleged that the company’s promoters Shankar Musnuri …

Brazil suspends clinical trials of Covaxin after Bharat Biotech terminates vaccine deal
3 years, 5 months ago

Brazil suspends clinical trials of Covaxin after Bharat Biotech terminates vaccine deal

India Today  

Brazil has suspended the clinical studies of Bharat Biotech's Covid-19 vaccine Covaxin after termination of the company's agreement with its partner, as per reports. "The suspension was carried out as a result of a statement from the Indian company Bharat Biotech Limited International, sent to Anvisa on Friday," the Brazilian health regulator said on Friday. Notwithstanding such termination, Bharat Biotech …

Brazil suspends $320 million deal with Bharat Biotech for Covaxin
3 years, 6 months ago

Brazil suspends $320 million deal with Bharat Biotech for Covaxin

Live Mint  

Brazil has suspended the contract for 20 million doses of Bharat Biotech International’s Covaxin worth about $320 million following a controversy over alleged irregularities in procurement and pricing. The contract between Bharat Biotech and Brazil’s Precisa Medicamentos has been at the centre of a political storm following a report by the parliamentary commission of inquiry on the Bolsonaro administration’s handling …

Brazil suspends contract to buy 20 mn doses of Bharat Biotech’s Covaxin over alleged irregularities
3 years, 6 months ago

Brazil suspends contract to buy 20 mn doses of Bharat Biotech’s Covaxin over alleged irregularities

Live Mint  

Brazil has suspended its contract worth around $320 million for 20 million doses of Bharat Biotech International’s Covaxin following allegations over the covid-19 vaccine’s procurement and pricing of $15 per dose. Emails between Bharat Biotech and the ministry submitted to CPI showed an initial quoted price of $1.34 per dose, which later rose to $15 per dose in the negotiated …

'Covaxin pricing clearly established': Bharat Biotech clarifies on Brazil deal row
3 years, 6 months ago

'Covaxin pricing clearly established': Bharat Biotech clarifies on Brazil deal row

India TV News  

Bharat Biotech on Wednesday issued a clarification over the procurement process of Covaxin in Brazil and other countries. However, procurement happens only post EUA In order to secure a firm Purchase Order from the country, the company proceeds to raise a Pro Forma Invoice to the MOH, towards the supply of the vaccine Based on the invoice, the MOH pays …

Brazil to suspend Covaxin deal with Bharat Biotech over allegations of irregularities by President
3 years, 6 months ago

Brazil to suspend Covaxin deal with Bharat Biotech over allegations of irregularities by President

India TV News  

Brazil has announced to suspend the Covaxin deal with Hyderabad-based laboratory Bharat Biotech. Brazil had in February signed a deal with Bharat Biotech to procure 20 million doses of Covaxin for USD 324 million. The South America country's Health Ministry had to pay USD 15 per vaccine dose to Precisa Medicamentos, the representative of Bharat Biotech in Brazil. Precisa, however, …

Step-by-step approach followed, no advance payment: Bharat Biotech on Brazil Covaxin row
3 years, 6 months ago

Step-by-step approach followed, no advance payment: Bharat Biotech on Brazil Covaxin row

India Today  

In the wake of Brazil suspending a $324-million deal for Covaxin shots over allegations of graft, the vaccine’s manufacturer, Bharat Biotech, has denied any wrongdoing and claimed it followed a "step-by-step" approach to get regulatory approval in the South American country. “In the specific case of procurement of Covaxin by MOH Brazil, since the first meetings with MOH Brazil during …

Brazil suspends Bharat Biotech's Covaxin order over graft allegations
3 years, 6 months ago

Brazil suspends Bharat Biotech's Covaxin order over graft allegations

India Today  

The Brazilian government, which agreed to purchase 20 million doses of Bharat Biotechs Covid-19 vaccine Covaxin, on Wednesday announced suspension of the contract following allegations of irregularities in the deal. According to CGU's preliminary analysis, there are no irregularities in the contract, but, due to compliance, the @minsaude opted to suspend the contract for further analysis," Brazil Health Minister Marcelo …

WHO’s approval for Covaxin: Bharat Biotech’s pre-submission meeting today. Why it is important?
3 years, 6 months ago

WHO’s approval for Covaxin: Bharat Biotech’s pre-submission meeting today. Why it is important?

Live Mint  

Covaxin Covid vaccine manufacturer Bharat Biotech is likely to attend a pre-submission meeting with World Health Organisation later today, a step that will take the vaccine maker closer to a WHO emergency use listing. The Hyderabad-based Bharat Biotech last month had submitted 90% of the documentation needed for WHO’s Emergency Use Listing, the company said. WHO's approval for Covaxin: Govt …

Brazil probes vaccine contract with India’s Bharat Biotech
3 years, 6 months ago

Brazil probes vaccine contract with India’s Bharat Biotech

Al Jazeera  

Prosecutors cite the drug’s high price, speedy talks and pending regulatory approvals as red flags for the contract. Brazilian federal prosecutors have opened an investigation into a contract worth 1.6 billion reals for 20 million doses of a COVID-19 vaccine made by India’s Bharat Biotech, according to a document seen by Reuters. The prosecutor-general’s office cited comparatively high prices, speedy …

Brazil probes Health Ministry deal to buy Covaxin vaccine
3 years, 6 months ago

Brazil probes Health Ministry deal to buy Covaxin vaccine

Associated Press  

RIO DE JANEIRO — Brazil’s federal prosecutor’s office is investigating possible irregularities in a Health Ministry contract to purchase 20 million doses of the Covaxin vaccine manufactured by Indian laboratory Bharat Biotech. The agreement signed in February commits the ministry to pay $320 million - at a cost of $15 per vaccine dose - to Precisa Medicamentos, the representative of …

Covaxin manufacturer Bharat Biotech to carry out clinical trials in US
3 years, 6 months ago

Covaxin manufacturer Bharat Biotech to carry out clinical trials in US

India TV News  

Covid-19 vaccine major Bharat Biotech said that it will be carrying out clinical trials in the United States to support the marketing application for Covaxin. The company will make Phase III trials data from the final analysis public soon," Bharat Biotech added. In a setback to Bharat Biotech's COVID-19 vaccine Covaxin, the US Food and Drug Administration has "recommended" Ocugen …

US FDA rejects emergency use authorisation for Bharat Biotech's COVID-19 jab Covaxin; all you need to know
3 years, 6 months ago

US FDA rejects emergency use authorisation for Bharat Biotech's COVID-19 jab Covaxin; all you need to know

Firstpost  

Covaxin had earlier suffered a similar impediment in securing World Health Organisation approvals after the world body said it needed more research data before it can grant the EUL Bharat Biotech’s coronavirus jab, Covaxin, which has been mired in controversy since its release in India, hit another roadblock Thursday as its US rollout plans were shelved temporarily. Bharat Biotech, however, …

Covid vaccine: Maharashtra pharma company getting ready for mass production of Covaxin
3 years, 7 months ago

Covid vaccine: Maharashtra pharma company getting ready for mass production of Covaxin

Live Mint  

Given the growing demand for vaccination against coronavirus, a pharma company in Maharashtra has come forward to prepare the mass production of Bharat Biotech's Covaxin to tide over the crisis. Haffkine Bio-Pharmaceutical Corporation Limited, a Maharashtra government undertaking, will have the capacity to produce over 22 crore doses of the Covid-19 vaccine every year once the requisite facilities are in …

Bharat Biotech Says Confident of Receiving WHO Nod for Covaxin in July-September Amid Travel Fear
3 years, 7 months ago

Bharat Biotech Says Confident of Receiving WHO Nod for Covaxin in July-September Amid Travel Fear

News 18  

NBharat Biotech has said it’s confident that the World Health Organisation would approve its Covid-19 jab, Covaxin, given its “experience of getting its other vaccines prequalified” by the global health body. In the wake of Covaxin not yet making it to the list of vaccines approved by WHO and several other countries, there are fears among people that this may …

Covaxin: Government reviews process to get WHO approval
3 years, 7 months ago

Covaxin: Government reviews process to get WHO approval

The Hindu  

The government on Monday “took stock” of Bharat Biotech’s application process with the World Health Organisation for regulatory clearances for the Covaxin vaccine, as an inter-ministerial group led by Foreign Secretary Harsh Shringla met with company representatives in Delhi. The meeting, that included senior officials from the Ministry of External Affairs, Ministry of Health, and Department of Biotechnology, with Bharat …

India may firm up plans to export Bharat Biotech’s Covaxin
3 years, 7 months ago

India may firm up plans to export Bharat Biotech’s Covaxin

Hindustan Times  

New Delhi: India has received enquiries from other countries for the export of the indigenous Covid 19 vaccine Covaxin jointly developed by Bharat Biotech and the Indian Council of Medical Research, according to government officials aware of the development. In February Bharat Biotech announced that it has signed a pact with Ocugen Inc, allowing the US-based biopharmaceutical firm to co-develop, …

India to push for Covaxin recognition by WHO and EU
3 years, 7 months ago

India to push for Covaxin recognition by WHO and EU

The Hindu  

Faced with concerns that Indians receiving the Covaxin vaccine may face travel restrictions, the government has decided to help ensure that Hyderabad-based Bharat Biotech receives clearances from both the World Health Organisation and subsequently, the EU’s European Medicines Agency. According to sources, the Ministry of External Affairs has been tasked with studying the matter, given both the need for recognition …

Bombay HC orders Maha govt to transfer vaccine plant to Bharat Biotech
3 years, 7 months ago

Bombay HC orders Maha govt to transfer vaccine plant to Bharat Biotech

Op India  

On Tuesday, the Bombay High Court permitted Biovet Private Limited, an associate company of Bharat Biotech, to take possession of a fully operational and ready-to-use vaccine manufacturing plant in Pune to produce Covaxin, the indigenous vaccine against Covid-19. Biovet then had to approach the High Court to challenge the refusal of the govt to approve the transfer of the plant, …

Bharat Biotech commences direct supply of COVID-19 vaccine Covaxin to 14 States
3 years, 7 months ago

Bharat Biotech commences direct supply of COVID-19 vaccine Covaxin to 14 States

The Hindu  

Bharat Biotech has commenced direct supply of its COVID-19 vaccine ‘Covaxin’ to 14 States, including Delhi and Maharashtra, with effect from May 1, according to the company’s Joint Managing Director Suchitra Ella. The Hyderabad-based firm has started supplying its COVID-19 treatment vaccine to the States based on the allocations received by the Central government. “Bharat Biotech confirms direct supplies of …

Bharat Biotech commences direct supply of 'Covaxin' to 14 states
3 years, 7 months ago

Bharat Biotech commences direct supply of 'Covaxin' to 14 states

India TV News  

Bharat Biotech has commenced direct supply of its COVID-19 vaccine 'Covaxin' to 14 states, including Delhi and Maharashtra, with effect from May 1, according to the company's Joint Managing Director Suchitra Ella. The Hyderabad-based firm has started supplying its COVID-19 treatment vaccine to the states based on the allocations received by the central government. "Bharat Biotech confirms direct supplies of …

Relaxing the Covaxin Patent is in the Interest of Bharat Biotech as well as Bharat
3 years, 8 months ago

Relaxing the Covaxin Patent is in the Interest of Bharat Biotech as well as Bharat

News 18  

India’s time for leadership is here—and yes, that time for leadership does indeed begin in the midst of the horrible crisis we are living through at the moment, where everything seems bleak and hope seems too far away. Far from it, the relaxation of Covaxin’s patent brings tangible benefits to Indians, the world, and most importantly, the manufacturer Bharat Biotech. …

Coronavirus | After Covishield, India’s Covaxin supply to Brazil hits roadblock
3 years, 9 months ago

Coronavirus | After Covishield, India’s Covaxin supply to Brazil hits roadblock

The Hindu  

After delays in the delivery of Covishield, supplies of Bharat Biotech’s Covaxin to Brazil too have run into trouble with Brazil’s health regulatory agency, ANVISA, deciding on Tuesday not to clear Covaxin for use at present. In a statement protesting the decision, Covaxin’s Brazilian import partner Precisa Medicamentos said it would appeal the ANVISA decision, which, diplomatic sources said, was …

Ocugen seeks to sell 100 million doses of 'Made in India' Covaxin in US
3 years, 9 months ago

Ocugen seeks to sell 100 million doses of 'Made in India' Covaxin in US

India Today  

Ocugen Inc seeks to sell 100 million doses of India’s state-backed Covid-19 vaccine Covaxin in the United States this year, the US firm’s chief executive Shankar Musunuri told Reuters on Monday. Musunuri said Ocugen aimed to launch the two-dose vaccine in the United States in the second quarter of 2021, initially with imported shots before beginning production there. Musunuri said …

81% Interim Efficacy Data Shot in the Arm for Bharat Biotech's Covaxin Export Hopes
3 years, 10 months ago

81% Interim Efficacy Data Shot in the Arm for Bharat Biotech's Covaxin Export Hopes

News 18  

The first interim review of Phase-3 trials for Bharat Biotech’s COVID-19 vaccine Covaxin revealed 81 percent efficacy, providing a boost to the Indian business, which is eyeing exports and hopes to join the World Health Organization’s COVAX program for vaccination in low- and middle-income countries. The first interim study is focused on 43 cases, with 36 cases of COVID-19 in …

Brazil signs deal with Bharat Biotech for 20 million doses of Covaxin
3 years, 10 months ago

Brazil signs deal with Bharat Biotech for 20 million doses of Covaxin

India TV News  

On the same day Brazil reached the grim milestone of 250,000 deaths by COVID-19, the country's health ministry signed a deal with Indian pharmaceutical company Bharat Biotech for the purchase of 20 million doses of the Covaxin vaccine, which is yet to be approved by local regulators. The administration of President Jair Bolsonaro said the first 8 million Covaxin shots, …

Tie-up with India's Serum Institute key to mass production of Covid vaccines, say pharma majors
3 years, 10 months ago

Tie-up with India's Serum Institute key to mass production of Covid vaccines, say pharma majors

India Today  

British-Swedish pharma giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of Covid-19 vaccines in partnership with the Serum Institute of India. Coronavirus Live Updates “Together with our partner, the Serum Institute of India, we plan to supply over 300 million doses to 145 countries through Covax in the first …

Brazil’s wealthy cause a stir trying to score quick vaccines
3 years, 11 months ago

Brazil’s wealthy cause a stir trying to score quick vaccines

Associated Press  

SAO PAULO — Brazilian marketing executive Eduardo Menga is extra cautious when it comes to his health. “When I go to a restaurant and I pay for my own food, I’m not taking anyone else’s food,” the 68-year-old Menga said from his home in Jundiai in Sao Paulo state. It could be an alternative line, and those who have the …

India to start Covid-19 vaccine exports from tomorrow: Report
3 years, 11 months ago

India to start Covid-19 vaccine exports from tomorrow: Report

Live Mint  

India, one of the world's biggest drugmakers, will start exports of Covid-19 vaccines as early as Wednesday, government sources said, paving the way for many mid-and lower-income countries to secure supplies of the easy-to-store Oxford/AstraZeneca vaccine. Two million doses of the vaccine, developed by AstraZeneca and Oxford University and manufactured by Serum Institute of India, will also be despatched to …

8.1 lakh Covaxin doses to be procured from Bharat Biotech for other countries
3 years, 11 months ago

8.1 lakh Covaxin doses to be procured from Bharat Biotech for other countries

India TV News  

The Union Health Ministry on Saturday asked the Ministry of External Affairs to consider contacting Bharat Biotech for the procurement of 8.1 lakh doses of Covaxin to be given to different countries as a goodwill gesture. According to an office memorandum accessed by IANS, Under Secretary to the government, G.K. Pillai, alluded to the meeting held between the Secretary at …

Bharat Biotech inks deal to supply Covaxin to Brazil
3 years, 11 months ago

Bharat Biotech inks deal to supply Covaxin to Brazil

India TV News  

Bharat Biotech on Tuesday announced it has signed an agreement with Precisa Medicamentos for the supplies of its Covid vaccine 'Covaxin' to Brazil. A team from Precisa Medicamentos visited the Bharat Biotech facility here last week to discuss potential export possibilities of Covaxin, India's first indigenous vaccine for Covid. Bharat Biotech has exceeded our expectations, demonstrating quality and safety at …

Coronavirus Vaccine: Bharat Biotech Signs Pact With Brazil for Supply of Covaxin
3 years, 11 months ago

Coronavirus Vaccine: Bharat Biotech Signs Pact With Brazil for Supply of Covaxin

News 18  

Bharat Biotech on Tuesday said it has signed an agreement with Precisa Medicamentos for the supply of its COVID-19 vaccine ‘Covaxin’ to Brazil. Covaxin has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and National Institute of Virology, the company said in a statement. As a company determined to protect global public health, it …

Serum Institute, Bharat Biotech Call Truce After Vaccine War, Say Both Committed to Smooth Rollout
4 years ago

Serum Institute, Bharat Biotech Call Truce After Vaccine War, Say Both Committed to Smooth Rollout

News 18  

A day after Bharat Biotech slammed Serum Institute of India CEO Adar Poonawalla for his ‘water’ comment, both vaccine makers on Tuesday jointly pledged for a smooth rollout of the antidote, saying saving lives and livelihoods was the most important task at hand. In a joint statement posted on their respective Twitter accounts, the companies said Serum Institute CEO Poonawalla …

SII, Bharat Biotech engage in war of words: A look at controversies surrounding vaccines cleared by DCGI
4 years ago

SII, Bharat Biotech engage in war of words: A look at controversies surrounding vaccines cleared by DCGI

Firstpost  

The verbal duel between the chiefs of Bharat Biotech and Serum Institute of India took place after the DCGI announced the approval of the Covaxin and Covishield vaccines The year 2021 has begun with an unseemly verbal duel between vaccine makers in India, with the heads of Serum Institute of India and Bharat Biotech making public allegations against each other. …

Bharat Biotech top boss slams criticism against indigenous vaccine, defends emergency authorisation
4 years ago

Bharat Biotech top boss slams criticism against indigenous vaccine, defends emergency authorisation

India Today  

The top boss of Bharat Biotech, the Indian pharmaceutical company that has developed the Covid-19 vaccine Covaxin in collaboration with the Indian Council for Medical Research, has slammed the criticism against the indigenous vaccine and its emergency approval. Here are the top quotes from Dr Krishna Ella’s press conference on Monday Criticism hurts Addressing the PC, Dr Ella said that …

Discover Related